CLPT
Clearpoint Neuro Inc
10.90$
-4.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +33.3% | +17.5% | +2.2% | -11.5% | -43.8% | -26.5% | -25.2% | -6.0% | +128.9% | +120.7% | +25.1% | +12.3% | +94.9% | +25.7% | -48.4% | |
| – | +303.3% | +105.2% | -28.2% | -39.6% | +91.0% | -43.0% | +29.8% | -1.1% | -35.1% | +36.4% | +90.6% | +98.6% | +47.3% | +13.6% | +18.4% | |
| – | – | – | – | – | – | – | +72.8% | -27.8% | -35.8% | -75.3% | +1,222.3% | +53.9% | – | – | – | |
| – | – | – | – | – | -193.7% | – | -262.4% | – | – | -392.5% | – | – | – | – | -801.5% | |
| – | -57.7% | +388.3% | +36.9% | -72.4% | +59.7% | +31.4% | -73.5% | +137.3% | +152.3% | +200.9% | -65.1% | +50.6% | +183.4% | -61.6% | +89.8% | |
| – | -57.7% | +388.3% | +36.9% | -72.4% | +59.7% | +31.4% | -73.5% | +137.3% | +152.3% | +200.9% | -65.1% | +6,290.5% | – | -103.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -52.8% | – | – | – | |
| – | – | – | – | – | – | -100.1% | -100.0% | – | +1,446.7% | +215.1% | -102.4% | -43.9% | -37.5% | – | – | |
| – | – | – | – | – | – | – | +0.0% | +0.0% | +6.9% | – | -100.0% | – | – | – | – | |
| – | -28.7% | +86.9% | +9.0% | +32.3% | -62.5% | -21.5% | +213.3% | -112.5% | – | +304.9% | +106.6% | -99.1% | -27.6% | +1,990.9% | +710.8% | |
| – | – | – | +28.6% | +202.1% | -167.0% | – | – | -203.6% | – | +455.1% | +136.1% | -177.9% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.